Clinical Trials
- Liver Cancer
Testing the Combination of New Anti-cancer Drug Peposertib with Avelumab and Radiation Therapy for Advanced/Metastatic Solid Tumors and Hepatobiliary Malignancies
- Phase 1 Cancers
A Phase 1/2, First-in-Human, Open-Label, Dose-Escalation Study of TAK-186 (Also Known as MVC-101), An EGFR x CD3 COnditional Bispecific Redirected Activation (COBRA) Protein in Patients With Unresectable Locally Advanced or Metastatic Cancer
- Phase 1 Cancers
A Phase 1 Dose Escalation and Expansion Study of EO-3021, an Anti-claudin 18.2 (CLDN18.2) Antibody Drug Conjugate, in Patients With Solid Tumors Likely to Express CLDN18.2
- Kidney Cancer, Melanoma
XTX301 in Patients With Advanced Solid Tumors
- Phase 1 Cancers
Study of ARTS-021 in Patients With Advanced Solid Tumors
- Phase 1 Cancers
test
- Ages18 years and older
- GenderBoth